Abstract
Post-acute ischemic stroke cognitive impairment frequently occurs and seriously affects patients daily activities. Recruitment of GluA2-containing Ca2+-impermeable AMPA receptors (CI-AMPARs) to hippocampal synaptic membrane surfaces was shown to trigger synaptic plasticity. Currently, the effect of CI-AMPAR trafficking on acute ischemic stroke remains poorly understood. β-Caryophyllene (BCP) has been shown to ameliorate cognitive impairment. However, the mechanism has not been characterized. In this study, a 60-min temporary middle cerebral artery occlusion (MCAO) model was established to simulate the pathology of acute ischemic stroke. BCP reduced neurologic deficits, cerebral infarct volume, and pathological damage in MCAO mice and caused CI-AMPARs to translocate to synaptic membranes in the hippocampus; surface expression of CI-AMPARs was also decreased in MCAO mice. Furthermore, this study also showed that BCP treatment significantly activated the cAMP/PKA pathway, which is consistent with the synaptic membrane expression of CI-AMPARs. To better understand the underlying mechanisms, the PKA inhibitor H-89 was used to study the role of BCP in MCAO mice. Interestingly, H-89 treatment significantly disrupted the BCP-mediated facilitation of CI-AMPAR translocation to the synaptic membrane surface and substantially attenuated BCP-induced protection against acute ischemic stroke. Additionally, inhibition the cAMP/PKA pathway not only reduced BCP-induced inhibition of AMPAR-mediated excitatory postsynaptic currents in the hippocampal CA1 region but also decreased the effect of BCP-mediated protection against post-acute ischemic stroke cognitive impairment. Taken together, these data indicate that PKA-dependent synaptic membrane surface recruitment of CI-AMPARs is crucial for the neuroprotective effect of BCP against acute ischemic stroke and protection against post-acute ischemic stroke cognitive impairment.
Highlights
Cognitive impairment occurs frequently after acute ischemic stroke and leads to poor long-term outcomes [1]
The results indicated that BCP can inhibit the AMPAR-mediated Miniature Excitatory Post Synaptic Currents (mEPSCs) in the hippocampus neuron induced by acute ischemic stroke
The results demonstrated that the cyclic adenosine monophosphate (cAMP)/PKA pathway is involved in BCP-induced inhibition of AMPAR-mediated mEPSCs in the hippocampus
Summary
Cognitive impairment occurs frequently after acute ischemic stroke and leads to poor long-term outcomes [1]. Prevention and treatment of cognitive impairment after acute ischemic stroke are essential for clinicians. Alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors (AMPARs) are the principle postsynaptic ionotropic glutamate receptors that mediate fast excitatory synaptic transmission in the central nervous system (CNS) [2, 3]. AMPARs are composed of four types of subunits, designated as GluA1, GluA2, GluA3, and GluA4, which combine to form tetramers [4]. GluA2 determines many of the major biophysical properties of AMPARs, including Ca2+ permeability, as Ca2+ plays a crucial role in many forms of synaptic plasticity [5]. The GluA2 strongly influences AMPAR assembly and trafficking, and plays pivotal roles in a number of forms of long-term synaptic plasticity [6]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
